非裔美国女性子宫浆液性癌的MicroRNA表达谱病例对照研究
本研究对29例子宫浆液性癌(USC)非裔美国患者与1:1匹配的白人对照进行肿瘤miRNA表达谱分析,共检测77份样本(54份肿瘤和23份正常子宫内膜)。结果未发现非裔与白人患者之间存在差异表达的miRNA,但miR-223上调与更差的总生存相关(TCGA独立数据集140例中p=0.0496,调整后HR 2.87,95%CI 1.00-8.27)。
要点
- 非裔与白人USC患者间未发现差异表达的miRNA。
- miR-223上调(>中位数)与USC患者更差的总生存相关。
- 辅助放疗在非裔美国患者中使用较少(p=0.03)。
核心结论
- miRNA表达谱未识别出非裔美国与白人USC患者之间的生物学差异。
- miR-223上调可能是USC的预后因素。
研究设计与样本
- 病例对照研究,29例非裔美国USC病例按年龄、分期和组织学亚型1:1计算机随机匹配白人对照。
- 共检测77份FFPE标本(54份肿瘤和23份匹配正常子宫内膜),使用miRCURY LNA microRNA Array进行miRNA表达谱分析。
主要发现
- 在分析的968个miRNA中,649个在正常子宫内膜与肿瘤间差异表达。
- 按种族、组织学亚型、分期或LVI存在与否比较,未发现差异表达的miRNA。
- 3年疾病复发患者中上调最显著的三个miRNA为miR-1、miR-21-5p和miR-223。
- 在TCGA独立数据集140例USC患者中,miR-223表达高于中位数与更差OS相关(p=0.0496)。
- 调整年龄、种族和BMI后,miR-223上调仍为死亡风险因素(调整HR 2.87,95%CI 1.00-8.27)。
关键数值与推荐
- 辅助放疗使用在非裔美国患者中较少见(p=0.03)。
- miR-223表达以中位数为界,高于中位数定义为上调。
临床怎么用
- miR-223上调可作为USC预后评估的潜在生物标志物。
- USC患者的miRNA表达谱分析未提示按种族区分的生物学差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Uterine serous carcinoma (USC) is an aggressive subtype of endometrial cancer associated with worse survival outcomes in African American (AA) patients. This study evaluated tumor miRNA expression by race, clinical and tumor characteristics, and survival outcomes. METHODS: FFPE tumor tissue from hysterectomy specimens was identified for 29 AA cases. Case matching was performed by computer-based random assignment in a 1:1 ratio with Caucasian controls based on age, stage and histologic subtype (pure vs. mixed). RNA was extracted from 77 specimens (54 tumors and 23 matched normal endometrium). MicroRNA array profiling was performed by microRNA Hi-Power Labeling (Hy3/Hy5) and hybridization to miRCURY LNA microRNA Array 7th Gen. RESULTS: Clinical and treatment characteristics were similar for cases and controls, although use of adjuvant radiation was less common in African Americans (p = 0.03). Of 968 miRNAs analyzed, 649 were differentially expressed in normal endometrium vs. tumor. When compared by race, histologic subtype, stage or presence of LVI, no differentially expressed miRNAs were identified. In patients with disease recurrence at 3 years, the three most upregulated miRNAs were miR-1, miR-21-5p and miR-223. Of these, increased miR-223 expression (>median) was associated with worse OS (p = 0.0496) in an independent dataset (TCGA dataset) comprising of 140 patients with USC (mixed or pure serous). After adjusting for age, ethnicity and BMI, upregulation of miR-223 remained risk factor for death (adjusted HR 2.87, 95% CI 1.00-8.27). CONCLUSIONS: MiRNA profiling did not identify biological differences between AA and Caucasian patients with USC. Upregulation of miR-223 may be a prognostic factor in USC.
引用
- Lee L, Howitt B, Cheng T, et al. MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma. Gynecol Oncol. 2021. PMID: 34607711. doi:10.1016/j.ygyno.2021.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。